Group Seeking Court Order to Halt CMS Medicare THC Hemp Marijuana Program

April 25, 2026 6:20 AM

A significant new filing submitted today in the U.S. District Court for the District of Columbia seeks an immediate injunction blocking the Centers for Medicare & Medicaid Services' controversial Substance Access Beneficiary Engagement Incentive (BEI) program, arguing the agency unlawfully created the first federal pathway allowing cannabinoid consumer products into Medicare without FDA approval or public rule making procedures. The filing,...

Read more

LighthouseAI Raises $8 Million Series A

April 24, 2026 2:45 PM

LighthouseAI, the central intelligence and management platform for pharmaceutical state licensing and compliance, today announced the close of an $8 million Series A financing round. The round was led by Boxcars Ventures, with participation from TGVP and existing investors.The company has doubled its customer base since January 2025 and now serves 250 customers across the pharmaceutical supply chain, including manufacturers, wholesale...

Read more

Dr. Alonso Martin Brings a Data-Driven Perspective on Longevity and Biological Age to The Marty Davis Show

April 24, 2026 2:00 PM

Dr. Alonso Martin, founder of BODYWELLE, recently appeared on The Marty Davis Show to explore the growing focus on longevity medicine, biological age, and personalized preventive care-an approach that is changing how many patients approach aging, healthspan, and long-term preventive care.Hosted by Miami business lawyer and entrepreneur Marty Davis, the episode examined why many individuals who appear "healthy" on routine lab work still...

Read more

Lance A. Slatton Joins CaregiverCompanion.ai as Official Brand Ambassador, Expanding Reach of Breakthrough AI Support for Family Caregivers

April 24, 2026 12:30 PM

CaregiverCompanion.ai, the free AI-powered platform created to support family caregivers, today announced that Lance A. Slatton, nationally known as "The Senior Care Influencer," has been named the company's Official Brand Ambassador. Founder and host of All Home Care Matters, the nation's leading caregiver-focused media platform and a trusted voice in long-term care, Slatton is widely respected throughout the healthcare and senior living...

Read more

Magicare Exits Stealth with $3.6M Pre-Seed to Build the Agentic Operating System for Post‑Acute Care

April 24, 2026 12:08 PM

Magicare.ai (formerly Exponential) today announced it is exiting stealth and has closed $3.6 million in pre-seed funding to scale a suite of AI agents purpose-built for post‑acute operators. Investors include leading operators and Mana Ventures, reflecting a shared thesis: the next generation of post‑acute software will not be another point solution - it will be an agentic operating system that runs complex workflows end-to-end with human...

Read more

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

April 24, 2026 9:21 AM

Sonoma Pharmaceuticals, Inc. (the "Company" or "Sonoma Pharmaceuticals") (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced the pricing of its public offering made on a firm commitment basis with gross proceeds to the Company expected to be approximately $4.0 million, before deducting fees and other expenses payable by the Company. The offering consists of 2,962,963 shares of common stock and...

Read more

Aetna Provider Survey Reveals Optimism and Opportunities to Simplify Health Care

April 24, 2026 9:00 AM

Aetna®, a CVS Health® company (NYSE:CVS) announced research findings from the inaugural Aetna Provider Survey, a quarterly study that polls a representative sample of the U.S. provider market to better understand their perceptions, opportunities, and challenges today and into the future. This survey series is intended to solicit timely, objective feedback from the U.S. provider market so we can identify opportunities to change the provider-payer...

Read more

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)

April 24, 2026 9:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer and age-related diseases, today announced the successful closing of its previously announced acquisition of TELI Pharmaceuticals, Inc. ("TELI").The transaction, which was approved by Telomir's shareholders at the Company's Annual Meeting held on March 23,...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Highlights Execution Momentum and Expanding AI Pipeline Following Strategic Growth Initiative

April 24, 2026 8:57 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today provided an operational update highlighting continued execution momentum and the expansion of its artificial intelligence platform following its recently announced strategic capital initiative. As the Company transitions into a revenue-focused phase, management is prioritizing the scaling of its newly launched consumer application, Snapshot Recipes, while simultaneously advancing...

Read more

Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)

April 24, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced the acceptance of two late breaking abstracts for the treatment of pediatric IF from MVID and SBS at the 58th Annual Meeting of ESPGHAN. These pediatric IF patients are receiving liquid oral crofelemer as an investigational drug under two separate investigator-initiated trials. One infant MVID IF patient is being treated with crofelemer as...

Read more

Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US

April 24, 2026 7:50 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that the TetraGraph System has secured inclusion in agreements with Vizient, Premier, and HealthTrust Performance Group, the three leading US Group Purchasing Organizations (GPOs). Approximately 95% of US hospitals engage with GPOs to support procurement processes, and these listings have the potential to expand and accelerate Senzime's market reach."Inclusion in all three major US GPO...

Read more

Senzime Publishes Annual and Sustainability Report for 2025

April 24, 2026 6:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) announces today that the company's annual and sustainability report for 2025 is published and available on www.senzime.com"2025 was the year we increased the growth rate and exceeded SEK 100 million in sales. We achieved our communicated goals for sales growth in constant currencies and kept costs according to plan. We secured several major strategic wins, strengthened our leading market...

Read more

Advanced Marketing Systems Drive Measurable Growth for Leading Plastic Surgery Clinics

April 24, 2026 3:50 AM

A growing number of leading plastic surgery clinics across major U.S. markets are adopting advanced, data-driven marketing systems to improve patient acquisition, streamline operations, and increase conversion rates. While patient-facing experiences in high-performing clinics may appear unchanged, significant transformation is taking place behind the scenes. Clinics are shifting away from fragmented marketing tactics toward fully integrated...

Read more

AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million

April 24, 2026 2:20 AM

AlzeCure Pharma AB (STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops small molecule drug candidates for CNS diseases, with a focus on Alzheimer's disease and pain, today announces that the Board of Directors, based on the authorization granted by the Annual General Meeting on 14 May 2025, has resolved on a new share issue of approximately SEK 30.1 million through the issuance of up to 22,982,891 shares at a subscription price of SEK...

Read more

Evotec Announces Chief Financial Officer Transition

April 24, 2026 1:50 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that Chief Financial Officer (CFO) Paul Hitchin will step down on April 30, 2026, for personal reasons unrelated to the company. The Supervisory Board has accepted Mr. Hitchin's decision and expressed deep appreciation for his leadership and significant contributions to the company. Since March 1, 2025, he successfully led Evotec through a significant financial and strategic...

Read more

Interim Report January - March 2026

April 24, 2026 1:50 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2026 (Jan-Mar)Net sales amounted to SEK 241.0 million (218.6), corresponding to growth of 10 percent in SEK.Organic growth was 23 percent in local currencies. Excluding revenue from heart trials the organic growth was 18 percent in local currencies.Thoracic sales increased by 27 percent in local currencies and by 19 percent excluding revenue from heart trials.Abdominal sales...

Read more

Psyence Group Inc. Announces Amendment to Amalgamation Agreement with GoldCoast Resource Corp.

April 23, 2026 6:30 PM

Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") is pleased to announce that it has entered into an amendment dated April 13, 2026 (the "Amendment") to the previously announced amalgamation agreement dated November 21, 2025, as amended (the "Amalgamation Agreement"), among Psyence, Psyence Therapeutics Corp. ("Psyence Subco") and GoldCoast Resource Corp. ("GoldCoast"), in connection with the proposed amalgamation transaction previously...

Read more

Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call

April 23, 2026 6:15 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the year ended December 31, 2025 and will have a conference call to present the Financial Results on April 27, 2026 at 8:30 am Eastern Time.Quarter and Year Ended December 31,...

Read more

Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies

April 23, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has advanced an analytical method used to measure and control a key polymer within its PNKP Inhibitor Technology (the "Technology"), supporting continued formulation development and scale-up as the Company advances toward its goal of clinical manufacturing. This work is intended to help ensure consistency in...

Read more

Hillsboro Health Recognized Among Nation's Top Rural Hospitals

April 23, 2026 5:05 PM

Hillsboro Health has been ranked one of the Top 20 Critical Access Hospitals in the nation for Best Practices in Patient Satisfaction by the National Rural Health Association. The recognition highlights Hillsboro Health's commitment to providing care that patients trust, value and recommend. The award places Hillsboro Health among the nation's top rural hospitals for patient satisfaction."This recognition shows the dedication of our team members...

Read more